Company news

Ehave Inc. (OTC:EHVVF) news

Ehave Inc. news releases on 6ix. Latest, May 19, 2026: AIBotics Enters Strategic AI Partnership and Joint Venture with ARYA AI Labs to Advance Next-Generation…

Ehave Inc. (OTC:EHVVF) news

Press releases & updates

AIBotics Enters Strategic AI Partnership and Joint Venture with ARYA AI Labs to Advance Next-Generation Deterministic “World Models”

Google Partner NovaCore Labs and AIBotics Advance Acquisition and Expand Robot Deployment Across Jamaica

AIBotics Crosses the Line from Concept to Cash Flow as 3DX Industries Commits to PHILL™ Production

Israeli Cannibble Food-Tech and AIBotics Enter Israel with Global Partner KEENON Robotics

AIBotics Ushers in a New Era as Intelligent Service Robotics Arrive in Tel Aviv, Redefining Human-Machine Interaction

AIBotics Signs LOI to Acquire Google Partner NovaCore Labs and Partners with KEENON Robotics to bring XMAN and Service Robots to Jamaica and the CARICOM

KEENON Robotics Sends First Shipment of Robots to Israel Post-War Under Agreement with AIBotics and Ignites Middle East Robotics Rollout

KEENON Robotics, Creator of XMAN and One of the World’s Global Leaders and Largest Robotic Manufacturers, Signs Partnership Agreement With Aibotics

AIBotics Launches First Pilot Program with One of Miami’s Elite Fitness Centers to Introduce Phill Robot™ in High-End Recovery Lounges

AIBotics, Inc. Issues Mid-Year Shareholder Update Highlighting Corporate Progress, Technology Development, and Strategic Roadmap for Agentic AI Integration

Ehave Snaps Up AI Headhunter for $10M, Signaling Commitment to AI

Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB

Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider KetaDASH to Launch Beta in Second Quarter 2021

Psychedelic Partnership Reached, Ehave Inc. and Brain Scientific Sign Memorandum of Understanding to Map Brain Response to Psychedelic Treatment, Collaborate in the Development of Neural Net Algorithms for the Psychedelic Mental Health Sector, E-Tattoo Te

Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics

20/20 Global Announces It Has Applied for a Name and Stock Symbol Change with FINRA

Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression

Ehave Looks to Expand KetaDASH to Palliative Care

20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST

Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare

Ehave Closes Transaction to Acquire CureDash Assets, Adds KetaDASH Home Delivery Service for Ketamine Clinics

Ehave Revolutionizes Patient Medical Records for Psychedelic Mental Health

Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector

Ehave Announces Asset Purchase Agreement with Zyus and Recapitalization Transactions

Ehave to Explore Strategic Alternatives

Ehave Leverages Cognitive Game Engine to Assess Cannabis Impairment

Ehave Provides Update on Companion Animal Informatics Platform to Include Use of Medical Cannabis

CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease

Hyperledger Continues Strong Momentum with 13 New Members

Ehave Solutions Gain Traction in Cannabis Industry -- CFN Media

Aequus and Ehave Enter Into Collaboration Agreement for Comprehensive Patient Data Management in Clinical Trials of Medical Cannabis

Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

Ehave Enters Blockchain Market for Secure Access of Patient Data in Mental Healthcare and Medical Cannabis

Ehave Announces Private Placement Transactions to Raise up to CDN$3 Million

Ehave to Host Facebook Live Q&A Session for Shareholders

CFN Media Exclusive CEO Interview: Ehave Connect and the Medical Marijuana Industry

Ehave Launches Baseline Concussion Assessment Tool on Ehave Connect

Ehave Looks to Validate Medical Cannabis through Right Data -- CFN Media

Ehave Announces Deployment of Machine Learning to Deliver Patient Insights for Mental Healthcare and Medical Cannabis

Ehave Expands into the Cannabis Industry -- CFN Media

Ehave Provides Update on Digital Portal Patient Intake

Ehave Announces Plans to Expand its Health Informatics Technology into Veterinary Medicine

Medical marijuana company partners with IT vendor to clinically assess cannabis therapies [Ehave Featured in Healthcare IT News]

Ehave Announces Integration of the Davidson Trauma Scale for PTSD into Ehave Connect

Ehave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal

Ehave Highlights Solutions to Support and Improve ADHD Treatment During ADHD Awareness Month

Ehave Highlights Recent Developments and Corporate Strategy in Updated Letter to Shareholders

Ehave Announces Launch of the Next Generation of the Ehave Platform and Ehave Connect to Facilitate Rapid Third-Party Content Integration

Aequus and Ehave Collaborate on Bioinformatics Platform for Management of Clinical Trials

Ehave Launches Conners® Suite of ADHD Assessment Tools for Ehave Connect